Jinjing Yao

Jinjing Yao

Auto-generated profile, based on publicly available information

Jinjing Yao

Department of Physiology and Pharmacology, Cumming School of Medicine, Libin Cardiovascular Institute, University of Calgary, Calgary, AB, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
BSBo Sun
Bo Sun
JYJinjing Yao
Jinjing Yao
MNMingke Ni
Mingke Ni
JWJinhong Wei
Jinhong Wei
XZXiaowei Zhong
Xiaowei Zhong
SCS.R. Wayne Chen
S.R. Wayne Chen
Clinical and basic studies shed light on the mechanism, diagnosis, and treatment of cardiac ryanodine receptor Ca 2+ release deficiency syndrome.

1 September 2020 in Cell Reports
Verified
Journal Article
Open access
JYJinjing Yao
Jinjing Yao
BSBo Sun
Bo Sun
AIAdam Institoris
Adam Institoris
XZXiaoqin Zhan
Xiaoqin Zhan
WGWenting Guo
Wenting Guo
SCS.R. Wayne Chen
S.R. Wayne Chen
Neuronal hyperactivity is an early primary dysfunction in Alzheimer’s disease (AD) in humans and animal models, but effective neuronal hyperactivity-directed anti-AD therapeutic agents are lacking. Here we define a previously unknown mode of ryanodine receptor 2 (RyR2) control of neuronal hyperactivity and AD progression. We show that a single RyR2 point mutation, E4872Q, which reduces RyR2 open time, prevents hyperexcitability, hyperactivity, memory impairment, neuronal cell death, and dendritic spine loss in a severe early-onset AD mouse model (5xFAD). The RyR2-E4872Q mutation upregulates hippocampal CA1-pyramidal cell A-type K+ current, a well-known neuronal excitability control that is downregulated in AD. Pharmacologically limiting RyR2 open time with the R-carvedilol enantiomer (but not racemic carvedilol) prevents and rescues neuronal hyperactivity, memory impairment, and neuron loss even in late stages of AD. These AD-related deficits are prevented even with continued β-amyloid accumulation. Thus, limiting RyR2 open time may be a hyperactivity-directed, non-β-amyloid-targeted anti-AD strategy.

1 March 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
FHFlorian Hiess
Florian Hiess
JYJinjing Yao
Jinjing Yao
ZSZhenpeng Song
Zhenpeng Song
BSBo Sun
Bo Sun
ZZZizhen Zhang
Zizhen Zhang
SCS.R. Wayne Chen
S.R. Wayne Chen
Ryanodine receptor 2 (RyR2) is abundantly expressed in the heart and brain. Mutations in RyR2 are associated with both cardiac arrhythmias and intellectual disability. While the mechanisms of RyR2-linked arrhythmias are well characterized, little is known about the mechanism underlying RyR2-associated intellectual disability. Here, we employed a mouse model expressing a green fluorescent protein (GFP)-tagged RyR2 and a specific GFP probe to determine the subcellular localization of RyR2 in hippocampus. GFP-RyR2 was predominantly detected in the soma and dendrites, but not the dendritic spines of CA1 pyramidal neurons or dentate gyrus granular neurons. GFP-RyR2 was also detected within the mossy fibers in the stratum lucidum of CA3, but not in the presynaptic terminals of CA1 neurons. An arrhythmogenic RyR2-R4496C+/− mutation downregulated the A-type K+ current and increased membrane excitability, but had little effect on the afterhyperpolarization current or presynaptic facilitation of CA1 neurons. The RyR2-R4496C+/− mutation also impaired hippocampal long-term potentiation, learning, and memory. These data reveal the precise subcellular distribution of hippocampal RyR2 and its important role in neuronal excitability, learning, and memory.

5 January 2022 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PDF file
JYJinjing Yao
Jinjing Yao
YLYajing Liu
Yajing Liu
BSBo Sun
Bo Sun
XZXiaoqin Zhan
Xiaoqin Zhan
JEJohn Paul Estillore
John Paul Estillore
SCS.R. Wayne Chen
S.R. Wayne Chen

5 August 2021 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
YLYajing Liu
Yajing Liu
JYJinjing Yao
Jinjing Yao
ZSZhenpeng Song
Zhenpeng Song
WGWenting Guo
Wenting Guo
BSBo Sun
Bo Sun
SCS.R. Wayne Chen
S.R. Wayne Chen

1 July 2021 in Neuroscience Letters
Verified
Journal Article
Closed access
BSBo Sun
Bo Sun
JYJinjing Yao
Jinjing Yao
ACAlexander W. Chen
Alexander W. Chen
JEJohn Paul Estillore
John Paul Estillore
RWRuiwu Wang
Ruiwu Wang
SCS.R. Wayne Chen
S.R. Wayne Chen